Japanese Licensed Exchange QRYPTOS to list FarmaTrust FTT Tokens
This content is provided by a sponsor
Qryptos is the cryptocurrency exchange and trading platform of QUOINE. The specific date of listing is to be finalised but it will be shortly after all due diligence is finished, following the successful completion of FarmaTrust’s TDE on 31st July 2018.
QRYPTOS Features
Top Class Security: The exchange utilizes multi-factor authentication, dedicated private servers, and bitcoin multi-sig wallets where funds are placed in offline cold storage.
Robust API: QRYPTOS has an open API that allows access to the key features of the platform.
Crisp Trades: QUOINE’s matching engine is capable of processing nearly one million transactions every second, providing a responsive user experience when placing orders
Analytics: QRYPTOS provides users with free charting trend indicators, live charts, and essential charting tools.
The Main Users of the QRYPTOS Website, by Traffic, Come From:
USA
Indonesia
Vietnam
India
United Kingdom
Raja Sharif, CEO of FarmaTrust Stated;
“Being listed on the right exchanges is fundamentally important to the people and institutions that have participated in the successful FarmaTrust TDE. We are thrilled that an exchange with the pedigree and reach of QRYPTOS has agreed to list the FTT Token. We are particularly pleased to have cemented the relationship with QUOINE as they are regulated by their financial services authority. FarmaTrust has gone through a similarly rigorous process of validation using FCA regulated BlueWater Capital in the UK.”
About QUOINE
QUOINE is a leading global fintech company that provides trading, exchange, and next-generation financial services powered by blockchain technology. With offices in Japan, Singapore and Vietnam, QUOINE combines a strong network of local partners with extensive team experience in banking and financial products to deliver best in class financial services for its customers.
In 2014, QUOINE launched Quoine Exchange, now known as QUOINEX, which became one of the largest bitcoin exchanges in the world by transaction volume. QUOINE offers powerful trading features, a sophisticated user dashboard, and secure regulatory compliance to individual and corporate customers.
QUOINEX provides trading services for major cryptocurrencies such as Bitcoin and Ethereum against fiat currency pairs in Japanese yen, US dollar, Euro, HK dollar, Indonesian rupiah, Singapore dollar, Philippine peso, and Australian dollar. QUOINEX has exceeded 55 billion USD in transactions in the past year.
In November 2017, QUOINE successfully raised 350M QASH (the equivalent of 350K ETH or 105M USD) in a token sale at https://liquid.plus, to fund the growth of the LIQUID platform.
In October 2017, QUOINE became the first licensed global cryptocurrency exchange in Japan to launch a global token sale.
QUOINE Corporation was officially licensed by the Japan FSA on 29th September 2017.
In June 2017, QUOINE launched a fully digital cryptocurrency exchange and trading platform called QRYPTOS, exclusively for cryptocurrency trading on the desktop version at www.qryptos.com.
About FarmaTrust
FarmaTrust is the most efficient global pharmaceutical tracking system, ensuring that counterfeit drugs do not enter the supply chain and providing security to pharmaceutical companies, governments, regulators and the public.
FarmaTrust’s blockchain based system utilises Artificial Intelligence, Machine Learning, and big data analysis to deliver value added services, efficiency, and a transparent supply chain. The FarmaTrust system is safe, secure, encrypted, immutable and future proof. FarmaTrust is based in London, United Kingdom.
Disclaimer: This publication is sponsored. Coinspeaker does not endorse or assume responsibility for the content, accuracy, quality, advertising, products, or other materials on this web page. Readers are advised to conduct their own research before engaging with any company mentioned. Please note that the featured information is not intended as, and shall not be understood or construed as legal, tax, investment, financial, or other advice. Nothing contained on this web page constitutes a solicitation, recommendation, endorsement, or offer by Coinspeaker or any third party service provider to buy or sell any cryptoassets or other financial instruments. Crypto assets are a high-risk investment. You should consider whether you understand the possibility of losing money due to leverage. None of the material should be considered as investment advice. Coinspeaker shall not be held liable, directly or indirectly, for any damages or losses arising from the use or reliance on any content, goods, or services featured on this web page.
